<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13874">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02926300</url>
  </required_header>
  <id_info>
    <org_study_id>KSB-CD-EXT</org_study_id>
    <nct_id>NCT02926300</nct_id>
  </id_info>
  <brief_title>Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)</brief_title>
  <official_title>Extension Study, An Open-labelled, Single Center, Comparative Phase I/IIa Clinical Trials to Evaluate the Efficacy and Safety of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kang Stem Biotech Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kang Stem Biotech Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical trial is to evaluate long-term safety and efficacy in patients
      who has history of FURESTEM-CD injection at least once.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ratio of patients who is applicable to CDAI&lt;150</measure>
    <time_frame>114 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>all kinds of adverse events which occur during the clinical sutdy</measure>
    <time_frame>114 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Crohn's Disease</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>stem cells</intervention_name>
    <description>IV infusion</description>
    <other_name>FURESTEM-CD Inj.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Gender: Both Age Limits: 20years to 70years Healthy Volunteers?: No.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who has history of FURESTEM-CD Inj. injection at least once.

          -  patients who understand and voluntarily sign an informed consent form.

        Exclusion Criteria:

          -  any other condition which the PI judges would make subject unsuitable for study
             participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>October 5, 2016</lastchanged_date>
  <firstreceived_date>November 11, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>crohn's disease</keyword>
  <keyword>stem cell therapy</keyword>
  <keyword>inflammatory bowel disease</keyword>
  <keyword>hUCB-MSC</keyword>
  <keyword>UCB-MSC</keyword>
  <keyword>Umbilical cord Blood</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
